Citadel Advisors’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 7079 |
|
|
2025
Q1 | – | Sell |
-200,405
| Closed | -$222K | – | 6993 |
|
|
2024
Q4 | $222K | Buy |
200,405
+199,692
| +28,007% | +$222K | ﹤0.01% | 4790 |
|
|
2024
Q3 | $499 | Sell |
713
-83,932
| -99% | -$58.7K | ﹤0.01% | 5658 |
|
|
2024
Q2 | $84.6K | Buy |
84,645
+39,567
| +88% | +$39.6K | ﹤0.01% | 5014 |
|
|
2024
Q1 | $107K | Buy |
45,078
+14,432
| +47% | +$34.2K | ﹤0.01% | 5053 |
|
|
2023
Q4 | $69K | Buy |
30,646
+29,036
| +1,803% | +$65.3K | ﹤0.01% | 5001 |
|
|
2023
Q3 | $3.41K | Sell |
1,610
-11,998
| -88% | -$25.4K | ﹤0.01% | 5560 |
|
|
2023
Q2 | $42K | Buy |
13,608
+136
| +1% | +$420 | ﹤0.01% | 5047 |
|
|
2023
Q1 | $72.5K | Sell |
13,472
-14,953
| -53% | -$80.4K | ﹤0.01% | 5034 |
|
|
2022
Q4 | $189K | Buy |
28,425
+6,028
| +27% | +$40.1K | ﹤0.01% | 4727 |
|
|
2022
Q3 | $89K | Sell |
22,397
-56,977
| -72% | -$226K | ﹤0.01% | 5150 |
|
|
2022
Q2 | $394K | Buy |
79,374
+21,765
| +38% | +$108K | ﹤0.01% | 4369 |
|
|
2022
Q1 | $348K | Buy |
57,609
+32,712
| +131% | +$198K | ﹤0.01% | 4805 |
|
|
2021
Q4 | $289K | Buy |
+24,897
| New | +$289K | ﹤0.01% | 5148 |
|